Correlation Between Poxel SA and Maat Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Poxel SA and Maat Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Poxel SA and Maat Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Poxel SA and Maat Pharma SA, you can compare the effects of market volatilities on Poxel SA and Maat Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Poxel SA with a short position of Maat Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Poxel SA and Maat Pharma.

Diversification Opportunities for Poxel SA and Maat Pharma

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Poxel and Maat is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Poxel SA and Maat Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maat Pharma SA and Poxel SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Poxel SA are associated (or correlated) with Maat Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maat Pharma SA has no effect on the direction of Poxel SA i.e., Poxel SA and Maat Pharma go up and down completely randomly.

Pair Corralation between Poxel SA and Maat Pharma

Assuming the 90 days trading horizon Poxel SA is expected to under-perform the Maat Pharma. In addition to that, Poxel SA is 2.01 times more volatile than Maat Pharma SA. It trades about -0.03 of its total potential returns per unit of risk. Maat Pharma SA is currently generating about 0.01 per unit of volatility. If you would invest  880.00  in Maat Pharma SA on August 27, 2024 and sell it today you would lose (114.00) from holding Maat Pharma SA or give up 12.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Poxel SA  vs.  Maat Pharma SA

 Performance 
       Timeline  
Poxel SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Poxel SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Maat Pharma SA 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Maat Pharma SA are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Maat Pharma may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Poxel SA and Maat Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Poxel SA and Maat Pharma

The main advantage of trading using opposite Poxel SA and Maat Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Poxel SA position performs unexpectedly, Maat Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maat Pharma will offset losses from the drop in Maat Pharma's long position.
The idea behind Poxel SA and Maat Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume